Comments
Merck becomes bigger Alzheimer's player, with new trial
04.12.2012. | (Reuters) - Merck & Co Inc has moved to the forefront of Alzheimer's disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein associated with the memory-robbing disease....
